Working…
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov.

Get the latest research information from NIH: https://www.nih.gov/coronavirus.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Sonographic Characteristics of Tumor Indices in Patients With Cervical Cancer During Chemo-radiotherpy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01562067
Recruitment Status : Unknown
Verified March 2011 by Rambam Health Care Campus.
Recruitment status was:  Not yet recruiting
First Posted : March 23, 2012
Last Update Posted : March 23, 2012
Sponsor:
Information provided by (Responsible Party):
Rambam Health Care Campus

Study Description
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:
Cervical tumors are characterized by vascular changes (in terms of quantity, volume and Flows) in the tumor. Due to a good access to the cervix through the vagina, these parameters can be assessed using a three dimensional supersonic. Sonographic characteristics of tumor indices measures before and after oncological treatments may shed light on the patient's prognosis.

Condition or disease Intervention/treatment
Cancer Device: ultrasound examination

Detailed Description:
no editional information. see above
Study Design
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Layout table for study information
Study Type : Observational
Estimated Enrollment : 40 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Sonographic Characteristics of Tumor Indices in Patients With Cervical Cancer During Chemo-radiotherpy
Study Start Date : March 2012
Estimated Primary Completion Date : April 2013
Estimated Study Completion Date : April 2014

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Cervical Cancer

Groups and Cohorts
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Intervention Details:
  • Device: ultrasound examination
    ultrasound and doppler studies to evaluate size and vascularity of tumor during radiotherapy
    Other Name: no other name

Outcome Measures
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. Sonographic characteristics of cervical tumors [ Time Frame: 5 years ]
    Sonographic characteristics of cervical tumors indices measures before and after oncological treatments may shed light on the patient's prognosis.


Biospecimen Retention:   Samples Without DNA
pap smear

Eligibility Criteria
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 70 Years   (Adult, Older Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
women with cervical cancer during radiotherapy
Criteria

Inclusion Criteria:

  • Cervical cancer patients intended to undergo chemotherapy or radiation, or both

Exclusion Criteria:

  • no exclusions
Contacts and Locations
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01562067


Locations
Layout table for location information
Israel
Rambam Medical Center
Haifa, Israel, 30196
Contact: amnon amit, md    97248543872 ext 3872    a_amit@rambam.health.gov.il   
Principal Investigator: amnon amit, md         
Sponsors and Collaborators
Rambam Health Care Campus
Investigators
Layout table for investigator information
Principal Investigator: amnon amit, md Rambam Health Care Campus
More Information
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information
Layout table for additonal information
Responsible Party: Rambam Health Care Campus
ClinicalTrials.gov Identifier: NCT01562067    
Other Study ID Numbers: 125-11CTIL
First Posted: March 23, 2012    Key Record Dates
Last Update Posted: March 23, 2012
Last Verified: March 2011
Keywords provided by Rambam Health Care Campus:
Cervical tumors,vascular changes,Sonographic characteristics
Additional relevant MeSH terms:
Layout table for MeSH terms
Uterine Cervical Neoplasms
Uterine Neoplasms
Genital Neoplasms, Female
Urogenital Neoplasms
 Neoplasms by Site
Neoplasms
Uterine Cervical Diseases
Uterine Diseases